0
0.5
1
1.5
2+
Mortality, day 28
6%
Improvement
Relative Risk
Mortality, day 15
12%
7-point scale
10%
7-point scale (b)
-2%
Remdesivir DISCOVERY LATE TREATMENT RCT
Is late treatment with remdesivir beneficial for COVID-19?
RCT 832 patients in multiple countries (March 2020 - January 2021)
No significant difference in outcomes seen
c19early.org
Ader et al., Lancet Infectious Diseases, Sep 2021
Favors remdesivir
Favors control